DHPPA - China Manufacturers, Suppliers, Factory

DHPPA, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

(R)-(+)-2-(4-Hydroxyphenoxy)propionic Acid (DHPPA) CAS 94050-90-5 Purity 99.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — (R)-(+)-2-(4-Hydroxyphenoxy)propionic Acid (DHPPA) CAS 94050-90-5 Purity >99.0% Optical Purity >99.0%
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...

2022.11.12 12:22:04
2022.09.11 11:13:55
2022.08.18 13:59:51
2022.07.25 03:46:31
2022.06.21 22:37:58
2021.12.20 22:29:49

DHPPA - China Manufacturers, Suppliers, Factory

Related Products

(R)-(+)-2-(4-Hydroxyphenoxy)propionic Acid (DHPPA) CAS 94050-90-5 Purity >99.0% Optical Purity >99.0%

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

2-Amino-5-Methylthiazole CAS 7305-71-7 Meloxicam Intermediate Purity >98.5% (GC) Factory

3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 Purity ≥99.0% (HPLC) Favipiravir Intermediate COVID-19

2-Bromo-5-Chloropyridine CAS 40473-01-6 Assay >98.0% (GC) Factory High Quality

Isoamyl Phenylacetate CAS 102-19-2 Purity >98.0% (GC) High Quality

N-Allylmethylamine CAS 627-37-2 Purity >98.0% (GC)

2-Aminopropanediamide CAS 62009-47-6 Favipiravir Intermediate COVID-19 High Purity

Guanine Hydrochloride CAS 635-39-2 Purity ≥99.5% Factory

Bis-Tris Propane CAS 64431-96-5 Purity >99.0% (Titration) Biological Buffer Extrapure Factory

5-Acetyluracil CAS 6214-65-9 Purity ≥99.0% (HPLC) Factory Hot Sale

H-D-Arg-NH2·2HCl CAS 203308-91-2 D-Arginine Amide Dihydrochloride >98.0% (HPLC)

1-Naphthoic acid CAS 86-55-5 Purity ≥99.0% (HPLC) Factory High Quality

L-2-Cyclohexylglycine CAS 14328-51-9 (H-Chg-OH) Purity >99.0% (TLC) Factory

New COVID treatments offer hope

Xi presents award to top scientists

Method Of Analyzing Palladium Content In Palladium Catalysts

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

2022.11.12 12:22:04

2022.09.11 11:13:55

2022.08.18 13:59:51

2022.07.25 03:46:31

2022.06.21 22:37:58

2021.12.20 22:29:49

related search